Welcome : Guest

Diamyd Medical AB (Sweden) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Diamyd Medical AB, which is principally a Medical Research Company. Illustrated with 43 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-12788
Price: $2150
Company Type: Public
Pages: 46
Date: October 2015
Market Data Tables: 43

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Diabetes Drugs......3
Table 1: Antidiabetes Molecules Market by Drug Worldwide (2015)-Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......3
Table 2: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......4
Table 3: Anti-Diabetic Drugs Market by Category in China (2015)-Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......5
Table 4: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......6
Table 5: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......7
Table 6: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......8
Table 7: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......9
Table 8: Diabetes Market by Segment in the US (2015)-Percentage Share Breakdown by Value for Anti-Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Pres cription Medication and Others......10
Table 9: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......11
Table 10: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......12
Table 11: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......13
Table 12: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2014)-Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......14
Table 13: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015)-Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......15
Table 14: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......16
Table 15: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......17
Table 16: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......18
Table 17: OTC Drug Sales by Category in China (2014) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others......19
Table 18: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......20
Table 19: Type II Diabetes Market by Insulin Treatment Worldwide (2015)-Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......21
Insulin......22
Table 20: Insulin Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog) and Rh Insulin......22
Table 21: Insulin Market by Generation in China (2014) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......23
Table 22: Insulin Market by Product Type in the US (2015)-Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......24
Table 23: Insulin Market by Type Worldwide (2015)-Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......25
Table 24: Insulin Market by Type Worldwide (2015)-Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......26
Table 25: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015)-Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......27
Anatomical Therapeutic Chemical (ATC-3) Indications......28
Table 26: Anatomical Therapeutic Chemical (ATC-3) Indications Market in Germany (2014) - Percentage Share Breakdown by Value Sales for A10C Human Insulin and Analogs, C09D Angiotensin II Antagonists, L01X Other Antineoplastic Agents, L03B Interferons, L04B Anti-TNF Preparations, L04X Other Immunosuppressants, N02A Analgesics, Narcotics, N03A Antiepileptics, N05A Antipsychotics, T02D Diabetes Tests, and Others......28
Table 27: Anatomical Therapeutic Chemical (ATC-3) Indications Market in Germany (2014) - Percentage Share Breakdown by Volume Sales for A02B Ulcer Treatments, B01C Anti-Platelet Treatments, C07A Beta-Blockers, Pure, M01A Anti-Phlog/Anti-Rheumatic, Non-Steroid, M02A Anti-Rheumatic and Analgesics, Topical, N02B Other Analgesics, R01A Nasal Preparations, Topical, R02A Throat Preparations, R05C Expectorants without Anti-Infectants, V03X Other Therapeutic Preparations, and Others......29
Diabetes Drugs......30
Table 28: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......30
Table 29: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......31
Table 30: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......32
Table 31: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......33
Insulin......34
Table 32: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co, Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......34
Table 33: Market Shares of Leading Insulin Companies in China (2015)-Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......35
Table 34: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......36
Table 35: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......37
Table 36: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......38
Table 37: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......39
Table 38: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......40
Table 39: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Cadila Pharmaceuticals Limited, Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Limited, Pfizer India Limited, Ranbaxy Laboratories Limited, Sanofi India Limited, Shreya Life Sciences Pvt. Ltd, USV Limited and Wockhardt Ltd.......41
Table 40: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......42
Table 41: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co, Ltd.......43
Table 42: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......44
Table 43: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......45